The surgeries took place at Krasnodar Regional Hospital in Krasnodar, Russia on June 19th and June 21st. The recipients of the implants, Julia T. and Aleksander Z., are recovering well. The implants in the procedures were developed by a U.S. based company, Nanofiber Solutions.
The transplants, which required more than a half-year of preparation, were performed on the first two patients enrolled in an ongoing clinical trial at Krasnodar Regional Hospital. The Russian Ministry of Health has approved a clinical protocol for an unlimited number of patients in this trial, all of which will involve trachea procedures.
Nanofiber Solutionss scaffolds mimic the body's physical structure and allow for a more successful seeding, growth and differentiation of stem cells. Because the cells used to regenerate the larynx and trachea were the patients' own, doctors report there has been no rejection of the transplants and the patients are not taking immunosuppressive drugs.
Huge step for regenerative medicine! Keep it up.
ReplyDelete